Sporet levering verden over | Forventet 9–14 hverdage

Din kurv

Din indkøbskurv er tom

Begynd at browse

Gratis fragt på ordrer over €500.

Subtotal€0
Gå til betaling
LevetidTidlig klinisk

Epithalon

Publiceret forskning og dokumentationsgrundlag

Epithalon (also written Epitalon) is a synthetic tetrapeptide, Ala-Glu-Asp-Gly (AEDG), derived from the pineal gland extract preparation Epithalamin. Published work reports induction of telomerase activity and telomere elongation in cultured human cells, modulation of circadian and pineal gene expression, antioxidant effects, and extension of median lifespan in Drosophila and rodent models. The great majority of this literature originates from a single Russian research group, with a small number of independent in vitro replications appearing between 2022 and 2025. No registered, placebo-controlled randomised trial of the tetrapeptide in humans has been published in the indexed literature.

Kort fortalt
  • Epithalon er et syntetisk tetrapeptid afledt af et ekstrakt fra pinealkirtlen.
  • Studier rapporterede telomeraseinduktion i humane celler og levetidsforlængelse hos fluer og gnavere.
  • Næsten al evidens kommer fra én russisk forskergruppe med ringe uafhængig replikation.

21 studier · 8 siden 2023 · nyeste 2026

Undersøgelser citeret
21
Publiceret 2023+
8
Nyeste artikel
2026
Sidst gennemgået
okt. 2026

Tilbagevendende temaer i litteraturen

  • telomerase induction
  • telomere length
  • pineal gland and melatonin regulation
  • circadian clock gene expression
  • geroprotection and lifespan
  • oxidative stress and antioxidant activity
  • epigenetic chromatin modification
  • cellular senescence markers

Stofidentifikatorer

CAS
307297-39-8
PubChem
219042

Regulatorisk status

Anbefalet af et FDA-rådgivende udvalg.

Den 23–24 July 2026 overvejede FDA's Pharmacy Compounding Advisory Committee Epithalon, hørt under navnet Epitalon, til 503A Bulks List og anbefalede dets tilføjelse. Heard under the spelling Epitalon and recommended on a divided vote. Published accounts of the meeting differ on the exact tally, so none is quoted here.

Dette er ikke en godkendelse. Udvalget rådgiver; det beslutter ikke. Anbefalingen er ikke bindende, FDA har ikke afsluttet regeludformningen, der formelt ville ændre noget, og inkludering på 503A Bulks List svarer ikke til FDA-godkendelse af et lægemiddel. Listen regulerer også apotekssammensætning til patienter, hvilket er en separat aktivitet fra levering kun til forskningsbrug.

Hvad den rådgivende afstemning i juli 2026 faktisk gjorde redegør for processen, de andre stoffer der blev hørt, og de fire ting afstemningen rutinemæssigt fejlrapporteres som betydende.

Kemisk identitet

Hvad Epithalon er, kemisk.

Molekylformel
C14H22N4O9
Molekylvægt
390.35 g/mol
CAS-nummer
307297-39-8
PubChem CID
219042
Også skrevet som

Epitalon, Epithalone

Disse tal stammer fra PubChem-posten for denne forbindelse og beskriver den frie base. Lyofiliseret peptid leveres normalt som et acetat- eller trifluoroacetatsalt og indeholder restvand, så massen af pulver i et hætteglas er ikke den samme mængde, som molekylvægten ovenfor ville antyde. Kromatografisk renhed på et analysecertifikat løser heller ikke den forskel — Sådan læses et analysecertifikat forklarer hvorfor.

Evidensen

21 offentliggjorte studier.

Sorteret efter styrken i studiedesignet og derefter efter nyhed. Hver post linker til sin kildepost, så fundet kan kontrolleres mod artiklen i stedet for at tages på vores ord.

  1. 01Humant klinisk2024· Russian (English abstract)

    Peptidergic regulation of expression of cellular aging marker proteins in buccal epithelium

    Ivko OM, et al. · Advances in Gerontology (Uspekhi Gerontologii) · buccal epithelial cells sampled from human subjects with disturbed melatonin secretion

    AEDG peptide administration was associated with reduced expression of the senescence-associated proteins p16, p21 and p53 in buccal epithelium. Circadian gene expression and melatonin secretion indices shifted toward values seen in younger subjects.

  2. 02Humant klinisk2020· Russian (English abstract)

    [AEDG peptide regulates human circadian rhythms genes expression during pineal gland accelerated aging.].

    Ivko OM, et al. · Adv Gerontol · clinical study in middle-aged people with reduced melatonin-producing pineal function (accelerated pineal ageing); n, route, duration and any control group not stated in the abstract

    The AEDG peptide was reported to increase urinary excretion of the melatonin metabolite 6-sulfatoxymelatonin in middle-aged people. In people with reduced melatonin production it normalised raised expression of the circadian genes Clock and Csnk1e in leukocytes and doubled the reduced expression of Cry2 in blood lymphocytes.

  3. 03Humant klinisk2011

    Peptide geroprotector from the pituitary gland inhibits rapid aging of elderly people: results of 15-year follow-up.

    Korkushko OV, et al. · Bull Exp Biol Med · randomized comparative study, n=79 elderly coronary patients (39 epithalamin + basic therapy vs 40 basic therapy alone), 3 years of treatment courses, 15-year follow-up

    Patients receiving six courses of epithalamin over 3 years in addition to basic therapy showed slower age-related decline of cardiovascular function and physical endurance, normalised circadian melatonin production and carbohydrate/lipid metabolism, and significantly lower mortality than controls.

  4. 04Humant klinisk2007· Russian (English abstract)

    [Normalizing effect of the pineal gland peptides on the daily melatonin rhythm in old monkeys and elderly people].

    Korkushko OV, et al. · Adv Gerontol · clinical and primate study: elderly people and old monkeys given pineal peptide preparations, both the extract Epithalamin and the synthetic tetrapeptide Epitalon; n not stated in the abstract

    Both preparations were reported to restore night-time release of endogenous melatonin and normalise its circadian rhythm in plasma; in elderly people with pineal insufficiency night melatonin rose. The abstract does not report results separately for Epitalon and Epithalamin, and the authors stated the preparations had no side effects.

  5. 05Humant klinisk2004

    Effect of peptide preparation epithalamin on circadian rhythm of epiphyseal melatonin-producing function in elderly people.

    Korkushko OV, et al. · Bull Exp Biol Med · randomized clinical study in healthy elderly people (n not stated in abstract)

    A course of epithalamin (pineal peptide preparation) modulated the circadian rhythm of plasma melatonin: night-time melatonin rose in subjects with initially low pineal activity and tended to fall in subjects with normal pineal function.

  6. 06Humant klinisk2003

    Peptides of pineal gland and thymus prolong human life

    Khavinson VKh, Morozov VG · Neuro Endocrinology Letters · 266 elderly subjects followed 6-8 years, thymic (Thymalin) and pineal (Epithalamin) peptide preparations

    The authors reported reduced mortality in peptide-treated elderly cohorts relative to controls over 6 to 8 years of follow-up, with the largest reduction in the combined Thymalin plus Epithalamin group. The report describes an open, non-randomised observational design and used the pineal extract preparation Epithalamin rather than the synthetic AEDG tetrapeptide.

  7. 07Humant klinisk2002

    Pineal-regulating tetrapeptide epitalon improves eye retina condition in retinitis pigmentosa.

    Khavinson V, et al. · Neuro Endocrinol Lett · controlled clinical trial in patients with degenerative retinal lesions (n not stated in abstract) plus Campbell rat model of retinitis pigmentosa

    In Campbell rats, Epitalon preserved retinal morphology and increased bioelectric and functional retinal activity. In patients with degenerative retinal lesions, a positive clinical effect was reported in 90% of cases.

  8. 08Dyr in vivo2003

    Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice

    Anisimov VN, et al. · Biogerontology · female Swiss-derived SHR mice, lifelong monthly subcutaneous dosing, lifespan and tumour incidence study

    Epitalon-treated female SHR mice showed an increase in maximum lifespan of approximately 12 percent relative to controls. Incidence of leukaemia was reduced, and the authors reported no increase in total spontaneous tumour incidence.

  9. 09Dyr in vivo2002

    Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.

    Anisimov VN, et al. · Int J Cancer · female HER-2/neu transgenic mice, Epitalon vs saline vs Vilon, monthly injection cycles from age 2 months

    Epitalon reduced the cumulative number and maximum size of spontaneous mammary tumors and the size (not number) of lung metastases, with 3.7-fold lower HER-2/neu mRNA expression in tumors versus controls. The comparator peptide Vilon increased mammary cancer incidence.

  10. 10Dyr in vivo2001

    Synthetic tetrapeptide epitalon restores disturbed neuroendocrine regulation in senescent monkeys

    Khavinson V, Goncharova N, Lapin B · Neuro Endocrinology Letters · old rhesus monkeys (Macaca mulatta), melatonin and cortisol circadian profiling

    Epitalon administration increased evening melatonin output in aged monkeys whose nocturnal melatonin rise had flattened. Disturbed circadian cortisol profiles were reported to move toward the pattern seen in young animals.

  11. 11Dyr in vivo2000

    Effect of epitalon on the lifespan increase in Drosophila melanogaster

    Khavinson VK, et al. · Mechanisms of Ageing and Development · Drosophila melanogaster, peptide administered during larval development

    Epitalon added to the medium during development increased adult Drosophila lifespan by roughly 11 to 16 percent. The effect was reported to be independent of concentration across the very low doses tested.

  12. 12In vitro2025

    Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity

    Al-Dulaimi S, Thomas R, Matta S, Roberts T · Biogerontology · human normal and breast cancer cell lines; qPCR telomere length assay and immunofluorescence

    Epitalon exposure was associated with increased telomere length in the cell lines tested, attributed to telomerase upregulation in normal cells and to alternative lengthening of telomeres (ALT) activity in cancer lines. A correction to this article was published in Biogerontology in November 2025 (PMID 41240216, doi 10.1007/s10522-025-10326-8).

  13. 13In vitro2025

    The Antioxidant Tetrapeptide Epitalon Enhances Delayed Wound Healing in an in Vitro Model of Diabetic Retinopathy

    Gatta M, et al. · Stem Cell Reviews and Reports · human retinal pigment epithelial cells under high-glucose conditions (in vitro diabetic retinopathy model)

    High-glucose culture delayed scratch-wound closure and raised reactive oxygen species in retinal pigment epithelial cells. Epitalon treatment restored wound closure and reduced markers of hyperglycaemia-induced epithelial-mesenchymal transition and fibrosis.

  14. 14In vitro2025

    Epitalon-activated telomerase enhance bovine oocyte maturation rate and post-thawed embryo development

    Ullah S, et al. · Life Sciences · bovine oocytes and cumulus cells; in vitro maturation and post-thaw embryo culture

    Epitalon supplementation increased telomerase activity in bovine oocytes and cumulus cells and raised in vitro maturation rates. Post-thaw blastocyst development and mitochondrial function measures were also improved relative to untreated controls.

  15. 15In vitro2024

    Short Peptides Protect Fibroblast-Derived Induced Neurons from Age-Related Changes

    Kraskovskaya N, et al. · International Journal of Molecular Sciences · induced neurons transdifferentiated from human fibroblasts of aged donors

    AEDG and related short peptides increased dendritic outgrowth in induced neurons derived from aged donor fibroblasts. Markers of oxidative DNA damage were reduced in treated cultures.

  16. 16In vitro2023

    Epigenetic Modification Under the Influence of Peptide Bioregulators on the "Old" Chromatin

    Lezhava T, Jokhadze T, Monaselidze J, et al. · Georgian Medical News · cultured lymphocytes from elderly human donors

    Peptide bioregulators including the AEDG tetrapeptide induced decondensation of constitutive heterochromatin in lymphocytes from elderly donors. Each peptide acted selectively on particular chromosome regions rather than uniformly across the genome.

  17. 17In vitro2022

    Epitalon protects against post-ovulatory aging-related damage of mouse oocytes in vitro

    Yue X, et al. · Aging (Albany NY) · mouse oocytes cultured 24 h post-ovulation

    Epitalon reduced reactive oxygen species accumulation and preserved mitochondrial membrane potential in post-ovulatory aged mouse oocytes. Spindle and chromosome abnormalities associated with post-ovulatory ageing were attenuated in treated oocytes.

  18. 18In vitro2020

    AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Mechanism

    Khavinson V, et al. · Molecules · human gingival mesenchymal stem cells undergoing neuronal differentiation, plus molecular docking

    AEDG peptide increased expression of neurogenesis markers including Nestin, GAP43, beta-tubulin III and doublecortin during neuronal differentiation. Molecular modelling indicated binding of the peptide to histone proteins and to DNA, which the authors proposed as an epigenetic mechanism.

  19. 19In vitro2003

    Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells

    Khavinson VKh, et al. · Bulletin of Experimental Biology and Medicine · human fetal fibroblast culture at the Hayflick limit

    Addition of Epithalon to human somatic cell cultures induced telomerase activity and telomere elongation. The authors reported that treated cultures underwent additional population doublings beyond the expected replicative limit. This is the foundational report underlying subsequent telomerase claims for the peptide.

  20. 20Gennemgang2026

    Therapeutic peptides in gerontology: mechanisms and applications for healthy aging

    Mavrych V, et al. · Frontiers in Aging · narrative review of nine therapeutic peptides used or investigated in aging research, including Epithalon

    The review placed Epithalon among investigational geroprotective peptides whose mechanistic rationale rests largely on preclinical data. The authors concluded that investigational peptides in this class require validation through well-designed clinical trials before therapeutic claims can be supported.

  21. 21Gennemgang2025

    Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties

    Araj SK, et al. · International Journal of Molecular Sciences · narrative review covering approximately 25 years of Epitalon literature

    The review summarised reported geroprotective, neuroendocrine, antioxidant and neuroprotective effects of the AEDG tetrapeptide. The authors stated that substantial gaps remain in the understanding of its molecular mechanism and clinical relevance.

Begrænsninger

Hvad denne evidens ikke fastslår.

The Epithalon evidence base is dominated by a single research group, the St Petersburg Institute of Bioregulation and Gerontology (Khavinson and colleagues), is largely published in Russian-language journals such as Uspekhi Gerontologii and Byulleten Eksperimentalnoi Biologii i Meditsiny, and has seen very little independent replication; the small number of independent papers are in vitro only. There are no published randomised, placebo-controlled, registered clinical trials of the synthetic AEDG tetrapeptide, most human reports used the pineal extract preparation Epithalamin in small open-label studies, some described as randomised but none placebo-controlled or blinded, the few in which the synthetic tetrapeptide itself was given are small Russian studies (one gave it together with Epithalamin), and human pharmacokinetics, dose-response and long-term safety, including any oncological risk from telomerase induction, remain uncharacterised.

Almindelige spørgsmål om forskningen.

What is Epithalon?

Epithalon is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly, abbreviated AEDG. It is the defined single-sequence analogue of Epithalamin, a pineal-gland polypeptide extract studied in Russian gerontology research, and it is supplied here as a lyophilised research material.

What does the telomerase research actually show?

One frequently cited in-vitro study reported that adding the peptide to telomerase-negative human fetal fibroblast cultures induced expression of the telomerase catalytic subunit, measurable enzymatic activity, and telomere elongation. That is a cell-culture observation. It has not been shown to translate into any clinical outcome, and nothing here should be read as a claim about ageing in humans.

How does Epithalon differ from Pinealon?

Both are short bioregulator peptides from the same Russian research programme, but they are different sequences with different literature. Epithalon is the tetrapeptide Ala-Glu-Asp-Gly studied mainly in pineal and telomere contexts; Pinealon is the tripeptide Glu-Asp-Arg studied mainly in neuronal models.

Fås i vores katalog

Kun til forskningsformål. Ikke til humant forbrug, diagnose, behandling eller forebyggelse af nogen tilstand. Intet på denne side er medicinsk rådgivning, og intet studie opsummeret her skal læses som en anbefaling.